PNC Financial Services Group’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$421K Buy
3,998
+1,039
+35% +$92K ﹤0.01% 1798
2025
Q4
$258K Buy
2,959
+221
+8% +$18.1K ﹤0.01% 2114
2025
Q3
$182K Buy
2,738
+324
+13% +$18.4K ﹤0.01% 2368
2025
Q2
$133K Buy
2,414
+422
+21% +$20.3K ﹤0.01% 2505
2025
Q1
$96.3K Buy
1,992
+551
+38% +$23.1K ﹤0.01% 2688
2024
Q4
$55.6K Sell
1,441
-288
-17% -$12.6K ﹤0.01% 3042
2024
Q3
$77.8K Buy
1,729
+1,715
+12,250% +$69.3K ﹤0.01% 2824
2024
Q2
$485 Buy
+14
New +$410 ﹤0.01% 4540
2024
Q1
Sell
-5
Closed -$115 4793
2023
Q4
$115 Sell
5
-110
-96% -$1.93K ﹤0.01% 4513
2023
Q3
$1.92K Hold
115
﹤0.01% 4255
2023
Q2
$3.18K Hold
115
﹤0.01% 4236
2023
Q1
$2.65K Buy
+115
New +$1.93K ﹤0.01% 4236

Other funds holding PTGX